Pfizer Hikes 2026 Sales Outlook by $500 Million on Second-Quarter Beat

3-line summary

• Pfizer raised its 2026 sales outlook by $500 million following a second-quarter earnings beat, according to the report.

This summary is our own processing of the source article; see the source link below for full context.